ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action – ABT
18 sept. 2022 13h00 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 18, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action – ABT
13 sept. 2022 16h00 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021...
ABBOTT LABORATORIES (NYSE: ABT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Abbott Laboratories (NYSE: ABT)
13 sept. 2022 01h45 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Abbott Laboratories? If so, please visit Abbott Laboratories Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com...
ABBOTT LABORATORIES (NYSE: ABT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Abbott Laboratories (NYSE: ABT)
07 sept. 2022 01h45 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Abbott Laboratories? If so, please visit Abbott Laboratories Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Abbott Laboratories Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – ABT
03 sept. 2022 15h34 HE
|
The Rosen Law Firm PA
NEW YORK, Sept. 03, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of...
Global Mucormycosis Treatment Market is estimated to be US$ 822.0 million by 2030 with a CAGR of 7.5% during the forecast period - by PMI
17 juin 2021 10h35 HE
|
PMI
Covina, CA, June 17, 2021 (GLOBE NEWSWIRE) -- The global Mucormycosis treatment market accounted for US$ 399.7 Million in 2020 and is estimated to be US$ 822.0 Million by 2030 and is anticipated to...
Global Embolic protection Devices Market is estimated to be US$ 1020.3 million by 2030 with a CAGR of 8.9% during the forecast period - by PMI
17 juin 2021 10h05 HE
|
PMI
Covina, CA, June 17, 2021 (GLOBE NEWSWIRE) -- The global Embolic protection devices market accounted for US$ 436.2 million in 2020 and is estimated to be US$ 1020.3 million by 2030 and is...
Transcatheter Mitral valve replacement Market is estimated to be US$ 14.5 billion by 2030 with a CAGR of 31.4% during the forecast period - by PMI
10 juin 2021 11h05 HE
|
PMI
Covina, CA, June 10, 2021 (GLOBE NEWSWIRE) -- The Transcatheter Mitral valve replacement market accounted for US$ 0.92 billion in 2020 and is estimated to be US$ 14.5 billion by 2030 and is...
Global Renal Biomarker Market is estimated to be US$ 2230.2 million by 2030 with a CAGR of 7.50% during the forecast period - by PMI
04 mai 2021 10h05 HE
|
PMI
Covina, CA, May 04, 2021 (GLOBE NEWSWIRE) -- The Global Renal Biomarker Market accounted for US$ 1084.5 million in 2020 and is estimated to be US$ 2230.2 million by 2030 and is anticipated to...
Global Pain Management Devices Market – Growing Demand for Long-Term Pain Management among the Geriatric Population, Strong Product Pipeline for Pain Management Devices etc. driving market growth - by PMI
19 janv. 2021 11h05 HE
|
PMI
Covina CA, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Growing demand for long-term pain management among the geriatric population, large patient population base, adverse effects of pain medications,...